vs
林德（LIN）与RYTHM, Inc.（RYM）财务数据对比。点击上方公司名可切换其他公司
RYTHM, Inc.的季度营收约是林德的1.2倍（$10.7M vs $8.8M），RYTHM, Inc.同比增速更快（242.0% vs 8.2%），过去两年RYTHM, Inc.的营收复合增速更高（102.6% vs -96.7%）
林德是全球知名跨国化工企业，按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立，现总部位于英国沃金，在爱尔兰注册，2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
RYTHM Inc.是一家临床阶段生物制药企业，专注于研发和商业化针对罕见遗传性内分泌与代谢疾病的创新疗法，主要面向美国市场，服务存在未被满足医疗需求的儿童及成人患者群体。
LIN vs RYM — 直观对比
营收规模更大
RYM
是对方的1.2倍
$8.8M
营收增速更快
RYM
高出233.7%
8.2%
两年增速更快
RYM
近两年复合增速
-96.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.8M | $10.7M |
| 净利润 | — | $-13.6M |
| 毛利率 | 48.5% | 75.5% |
| 营业利润率 | 27.8% | -121.5% |
| 净利率 | — | -127.6% |
| 营收同比 | 8.2% | 242.0% |
| 净利润同比 | — | 44.1% |
| 每股收益（稀释后） | $3.98 | $-6.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LINRYM
| Q1 26 | $8.8M | — | ||
| Q4 25 | $8.8B | $10.7M | ||
| Q3 25 | $8.6B | $4.0M | ||
| Q2 25 | $8.5B | $2.0M | ||
| Q1 25 | $8.1B | $538.0K | ||
| Q4 24 | $8.3B | $-7.5M | ||
| Q3 24 | $8.4B | $1.9M | ||
| Q2 24 | $8.3B | $3.0M |
净利润LINRYM
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $-13.6M | ||
| Q3 25 | $1.9B | $-10.7M | ||
| Q2 25 | $1.8B | $-7.4M | ||
| Q1 25 | $1.7B | $-1.6M | ||
| Q4 24 | $1.7B | $-24.4M | ||
| Q3 24 | $1.6B | $-18.7M | ||
| Q2 24 | $1.7B | $-3.0M |
毛利率LINRYM
| Q1 26 | 48.5% | — | ||
| Q4 25 | — | 75.5% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 16.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | — | 37.6% |
营业利润率LINRYM
| Q1 26 | 27.8% | — | ||
| Q4 25 | 23.0% | -121.5% | ||
| Q3 25 | 27.5% | -219.8% | ||
| Q2 25 | 27.7% | -332.9% | ||
| Q1 25 | 26.9% | -687.9% | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 25.0% | -63.1% | ||
| Q2 24 | 26.4% | -28.5% |
净利率LINRYM
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | -127.6% | ||
| Q3 25 | 22.4% | -263.8% | ||
| Q2 25 | 20.8% | -360.4% | ||
| Q1 25 | 20.6% | -302.2% | ||
| Q4 24 | 20.8% | 324.4% | ||
| Q3 24 | 18.5% | -964.4% | ||
| Q2 24 | 20.1% | -99.3% |
每股收益（稀释后）LINRYM
| Q1 26 | $3.98 | — | ||
| Q4 25 | $3.28 | $-6.78 | ||
| Q3 25 | $4.09 | $-5.33 | ||
| Q2 25 | $3.73 | $-3.74 | ||
| Q1 25 | $3.51 | $-0.83 | ||
| Q4 24 | $3.61 | $-24.26 | ||
| Q3 24 | $3.22 | $-17.28 | ||
| Q2 24 | $3.44 | $-3.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $32.2M |
| 总债务越低越好 | $24.7M | $80.6M |
| 股东权益账面价值 | $40.1M | $13.0M |
| 总资产 | $86.3M | $106.7M |
| 负债/权益比越低杠杆越低 | 0.62× | 6.19× |
8季度趋势，按日历期对齐
现金及短期投资LINRYM
| Q1 26 | $4.0M | — | ||
| Q4 25 | $5.1B | $32.2M | ||
| Q3 25 | $4.5B | — | ||
| Q2 25 | $4.8B | $41.0M | ||
| Q1 25 | $5.3B | $24.4M | ||
| Q4 24 | $4.8B | — | ||
| Q3 24 | $5.2B | $267.0K | ||
| Q2 24 | $4.6B | $57.0K |
总债务LINRYM
| Q1 26 | $24.7M | — | ||
| Q4 25 | $20.7B | $80.6M | ||
| Q3 25 | $18.6B | $90.6M | ||
| Q2 25 | $19.7B | $40.6M | ||
| Q1 25 | $17.6B | $10.6M | ||
| Q4 24 | $15.3B | — | ||
| Q3 24 | $17.5B | $6.2M | ||
| Q2 24 | $16.9B | $4.6M |
股东权益LINRYM
| Q1 26 | $40.1M | — | ||
| Q4 25 | $38.2B | $13.0M | ||
| Q3 25 | $38.6B | $11.7M | ||
| Q2 25 | $38.5B | $21.0M | ||
| Q1 25 | $38.0B | $26.8M | ||
| Q4 24 | $38.1B | $28.1M | ||
| Q3 24 | $39.2B | $5.5M | ||
| Q2 24 | $38.2B | $8.5M |
总资产LINRYM
| Q1 26 | $86.3M | — | ||
| Q4 25 | $86.8B | $106.7M | ||
| Q3 25 | $86.0B | $115.2M | ||
| Q2 25 | $86.1B | $69.5M | ||
| Q1 25 | $82.7B | $45.6M | ||
| Q4 24 | $80.1B | $54.0M | ||
| Q3 24 | $82.5B | $39.0M | ||
| Q2 24 | $80.2B | $39.4M |
负债/权益比LINRYM
| Q1 26 | 0.62× | — | ||
| Q4 25 | 0.54× | 6.19× | ||
| Q3 25 | 0.48× | 7.73× | ||
| Q2 25 | 0.51× | 1.94× | ||
| Q1 25 | 0.46× | 0.40× | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.45× | 1.13× | ||
| Q2 24 | 0.44× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | $898.0K | — |
| 自由现金流率自由现金流/营收 | 10.2% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | — |
8季度趋势，按日历期对齐
经营现金流LINRYM
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $-3.0M | ||
| Q3 25 | $2.9B | $-5.4M | ||
| Q2 25 | $2.2B | $-8.4M | ||
| Q1 25 | $2.2B | $-6.7M | ||
| Q4 24 | $2.8B | $-5.3M | ||
| Q3 24 | $2.7B | $-1.4M | ||
| Q2 24 | $1.9B | $-1.8M |
自由现金流LINRYM
| Q1 26 | $898.0K | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $954.0M | — | ||
| Q1 25 | $891.0M | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $796.0M | $-1.8M |
自由现金流率LINRYM
| Q1 26 | 10.2% | — | ||
| Q4 25 | 17.9% | — | ||
| Q3 25 | 19.4% | — | ||
| Q2 25 | 11.2% | — | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | 18.8% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 9.6% | -61.2% |
资本支出强度LINRYM
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | — | ||
| Q3 25 | 14.8% | — | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | 15.7% | — | ||
| Q4 24 | 15.1% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | 13.7% | 0.1% |
现金转化率LINRYM
| Q1 26 | — | — | ||
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.29× | — | ||
| Q4 24 | 1.63× | — | ||
| Q3 24 | 1.76× | — | ||
| Q2 24 | 1.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIN
暂无分部数据
RYM
| Nonlicensing Revenue | $9.5M | 89% |
| Cultivation Business Discontinued Operations | $1.2M | 11% |
